Zoetis to release Carysta HVC in March
The in-house diagnostic system is marketed to high-volume veterinary hospitals.
Zoetis Inc. is planning the March 2018 release of Carysta HVC, a tabletop diagnostic device for busy veterinary hospitals.
The chemistry machine is designed to perform up to 37 tests individually or as fully customizable panels, the company reported Feb. 5.
HVC stands for high-volume chemistry, a nod to high-volume veterinary clinics that desire “improved productivity at a lower cost” and “reference laboratory-quality results,” said Lisa Lee, vice president of U.S. Diagnostics and Business Solutions at Zoetis.
The system can run multiple patient samples simultaneously using minimal sample volumes, the Parsippany, New Jersey, company stated.
Zoetis will distribute the machine through an exclusive partnership with DiaSys Diagnostic Systems USA of Wixom, Michigan.